Uncovering the reasons behind irregular visits by patients with type 2 diabetes mellitus
DOI:
https://doi.org/10.35730/jk.v15i2.1095Keywords:
Diabetes mellitus, Puskesmas, type 2 DM, visit irregularityAbstract
Background: Type 2 diabetes mellitus (DM) is a non-communicable disease with an increasing incidence. DM is associated with deaths caused by several complications. One of the efforts to manage DM is to control blood glucose by maintaining regular check-ups and treatment compliance. Unfortunately, many people with DM still need to visit health facilities regularly.
Purpose: This study aimed to explain the factors associated with the irregularity of type 2 DM patients having check-ups at the public health center (puskesmas).
Methods: This cross-sectional study used the medical record data from Grabag II Public Health Center. The subjects were 135 outpatients with type 2 DM and complete medical records.
Results: The results showed that visit irregularity was significantly associated with sex (OR = 3.8; 95% CI = 1.12-12.79), distance from home (OR = 0.2; 95% CI = 0.06-0.52), and duration of diagnosis (OR = 0.3; 95% CI= 0.12-0.85), but not with age, insurance, comorbidities, and types of therapy.
Conclusion: Factors associated with type 2 diabetes mellitus patients' irregular visits to Puskesmas are sex, distance from home, and duration of diagnosis. Educational interventions at all levels of society should be carried out to increase knowledge about DM and the importance of regular check-ups and medication
References
D. Purnamasari, “The emergence of non-communicable Disease in Indonesia,” Acta Med. Indones., vol. 50, no. 4, pp. 273–274, 2018, [Online]. Available: https://www.actamedindones.org/index.php/ijim/article/view/1028/339
Kementerian Kesehatan RI Badan Penelitian dan Pengembangan Kesehatan, Laporan Nasional RISKESDAS 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan, 2019.
J. A. Campbell and L. E. Egede, “Individual-, Community-, and Health System-Level Barriers to Optimal Type 2 Diabetes Care for Inner-City African Americans: An Integrative Review and Model Development,” Diabetes Educ, vol. 46, no. 1, pp. 11–27, 2020, doi: 10.1177/0145721719889338.
World Health Organization, “Diabetes,” 2023. https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed May 02, 2023).
N. Rasdianah, S. Martodiharjo, T. M. Andayani, and L. Hakim, “Pengaruh Pelayanan Kefarmasian di Rumah pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Wilayah Kota Yogyakarta,” J. Manaj. DAN PELAYANAN Farm. (Journal Manag. Pharm. Pract., vol. 10, no. 2, p. 126, 2020, doi: 10.22146/jmpf.46240.
A. K. Sendekie, A. K. Netere, A. E. Kasahun, and E. A. Belachew, “Medication adherence and its impact on glycemic control in type 2 diabetes mellitus patients with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia,” PLoS One, vol. 17, no. 9, p. e0274971, 2022, doi: 10.1371/journal.pone.0274971.
N. Xu, S. Xie, Y. Chen, J. Li, and L. Sun, “Factors influencing medication non-adherence among chinese older adults with diabetes mellitus,” Int J Env. Res Public Heal., vol. 17, no. 17, p. 6012, 2020, doi: 10.3390/ijerph17176012.
A. A. Tambuwun, G. D. Kandaou, and J. E. Nelwan, “Hubungan Karakteristik Individu Dengan Kepatuhan Berobat Pada Penderita Hipertensi Di Puskesmas Wori Kabupaten Minahasa Utara,” J. Kesmas, vol. 10, no. 4, pp. 112–121, 2021.
E. Erawatyningsih, P. Purwanta, and H. Subekti, “Faktor- faktor yang mempengaruhi ketidakpatuhan berobat pada penderita tuberkulosis paru,” Ber. Kedokt. Masy., vol. 25, no. 3, pp. 117–124, 2009, doi: 10.4236/cs.2016.710288.
M. A. Barimbing, F. T. Feoh, and F. Y. Maromon, “Hubungan Akses Ke Pelayanan Kesehatan Dengan Kepatuhan Kontrol Berobat Pasien Skizofrenia,” J. Nurs. Updat., vol. 12, no. 4, pp. 213–220, 2021.
I. R. C. E. S. Caetano, L. M. Santiago, and M. Marques, “Impact of written information on control and adherence in type 2 diabetes,” Rev Assoc Med Bras, vol. 64, no. 2, pp. 140–147, 2018, doi: 10.1590/1806-9282.64.02.140.
N. H. M. Haskani, H. P. Goh, D. V. T. Wee, A. Hermansyah, K. W. Goh, and L. C. Ming, “Medication Knowledge and Adherence in Type 2 Diabetes Mellitus Patients in Brunei Darussalam: A Pioneer Study in Brunei Darussalam,” Int J Env. Res Public Heal., vol. 19, no. 12, p. 7470, 2022, doi: 10.3390/ijerph19127470.
T. Sohal, P. Sohal, K. M. King-Shier, and N. A. Khan, “Barriers and facilitators for type-2 diabetes management in south asians: A systematic review,” PLoS One, vol. 10, no. 9, p. e0136202, 2015, doi: 10.1371/journal.pone.0136202.
S. Baghikar, A. Benitez, P. Fernandez Piñeros, Y. Gao, and A. A. Baig, “Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes,” J Immigr Minor Heal., vol. 21, no. 6, pp. 1334–1341, 2019, doi: 10.1007/s10903-019-00867-9.
BPJS, “Rujuk Balik di Era JKN,” 2014. https://bpjs-kesehatan.go.id/bpjs/index.php/post/read/2014/261/Rujuk-Balik-di-Era-JKN/berita (accessed Apr. 03, 2023).
E. Zairina et al., “Factors related to barriers and medication adherence in patients with type 2 diabetes mellitus: a cross-sectional study,” J Diabet Metab Disord, vol. 21, no. 1, pp. 219–228, 2022, doi: 10.1007/s40200-021-00961-6.
